The treatment survival rate is over 87%, and the stem cell type bioartificial liver project has been approved for clinical use and is being promoted for commercialization.

With financial support of up to 30 million yuan, Shanghai issued the Shanghai Action Plan for promoting Gene Therapy Scientific and technological Innovation and Industrial Development (2023-2025).

Progress of Stem cell drug registration and application in China (August 2023)

Approved for marketing: (MSC) Stem Cell drug price list and ranking.

Overview of the development of biomedicine industry in Pudong New Area of Shanghai.

Thirteen cell therapies have been introduced in the clinic | this year.

Global future biomedical industry layout and China's key research direction.

The State Medical Insurance Bureau issued a document: Clearly the scope of consumables included in the medical insurance payment.